{"gene":"ERCC2","run_date":"2026-06-09T23:54:43","timeline":{"discoveries":[{"year":1994,"finding":"ERCC2/XPD protein co-purifies with the RNA polymerase II transcription factor BTF2/TFIIH; antibodies against ERCC3 (p89) or p62 subunit of BTF2 can immunoprecipitate ERCC2, and conversely an anti-ERCC2 antibody retains BTF2. ERCC2 can be salt-resolved from other BTF2 components, and its re-addition enhances BTF2 transcription activity, indicating ERCC2 is a functional subunit of TFIIH involved in both NER and transcription.","method":"Co-purification, immunoprecipitation, glycerol gradient sedimentation, transcription activity reconstitution","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — reciprocal immunoprecipitation plus functional reconstitution of transcription activity; foundational paper replicated extensively","pmids":["8194528"],"is_preprint":false},{"year":1996,"finding":"XPD (ERCC2) and XPB are components of the p53-mediated apoptosis pathway. Primary fibroblasts from XP-D patients (deficient in XPD) have a deficiency in p53-induced apoptosis that can be rescued by transferring wild-type XPD gene into the mutant cells. XP-D lymphocytes also show decreased apoptotic response to DNA damage by adriamycin. XP-A and XP-C mutant cells do not show this apoptotic deficiency, placing XPD specifically in the p53 apoptotic pathway downstream of p53 but upstream of ICE-family caspases.","method":"Microinjection of p53 expression vector into primary fibroblasts, retroviral infection, genetic complementation with wild-type XPD gene, comparison across XP complementation groups","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic rescue by wild-type gene in patient cells, epistasis across multiple XP complementation groups, multiple orthogonal methods","pmids":["8675009"],"is_preprint":false},{"year":2003,"finding":"Drosophila Xpd negatively regulates CAK (Cdk7-cyclin H-MAT1) activity within TFIIH. Excess Xpd titrates CAK activity, resulting in decreased Cdk T-loop phosphorylation, mitotic defects, and lethality; conversely, reduced Xpd increases CAK activity and cell proliferation. Xpd is downregulated at the onset of mitosis, which appears to upregulate mitotic CAK activity and promotes mitotic progression.","method":"Drosophila genetics (overexpression and loss-of-function), Cdk T-loop phosphorylation assays, mitosis/lethality phenotype analysis","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — gain- and loss-of-function in intact organism with biochemical readout (CAK phosphorylation), mechanistic pathway placement","pmids":["12853965"],"is_preprint":false},{"year":2006,"finding":"XPD (and FancJ) contain a conserved iron-sulfur (Fe-S) cluster domain near the N-terminus coordinated by three absolutely conserved cysteine residues; this Fe-S cluster is essential for XPD helicase activity. Yeast strains with mutations in the Fe-S domain of Rad3 (yeast XPD ortholog) are defective in UV photoproduct excision repair. Clinically relevant TTD mutations disrupt the Fe-S cluster and abolish helicase activity.","method":"Biochemical Fe-S cluster characterization, site-directed mutagenesis of cysteine ligands, in vitro helicase assays, yeast genetic complementation/UV repair assay","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro mutagenesis and helicase assays combined with yeast genetic complementation; replicated in parallel by structural studies","pmids":["16973432"],"is_preprint":false},{"year":2008,"finding":"Crystal structure of XPD catalytic core (from Sulfolobus acidocaldarius) reveals four domains: two Rad51/RecA-like helicase domains (HD1, HD2), a 4FeS domain, and an Arch domain forming a substrate-binding groove. XP mutations along HD1 ATP-binding edge and HD2 DNA-binding channel impair helicase activity essential for NER. XP/CS mutations both impair helicase activity and likely affect HD2 functional movement. TTD mutants map to sites in all four domains causing framework defects that impair TFIIH integrity.","method":"X-ray crystallography, in vitro helicase activity assays, mutation analysis","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure combined with biochemical mutant activity assays, disease mutation mapping; independently replicated by second crystal structure paper same year","pmids":["18510924"],"is_preprint":false},{"year":2008,"finding":"2.25 Å crystal structure of XPD from Sulfolobus tokodaii confirms four-domain organization and reveals that XPD has 5'-to-3' polarity; helicase activity is dependent on the iron-sulfur cluster binding domain. Detailed biochemical analyses provide molecular basis for helicase mechanism and explain phenotypes of XPD mutations in humans.","method":"X-ray crystallography (2.25 Å), biochemical helicase assays","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — high-resolution crystal structure with biochemical validation; independent lab, same year as companion paper","pmids":["18510925"],"is_preprint":false},{"year":2010,"finding":"XPD forms a TFIIH-independent protein complex called MMXD containing MMS19, MIP18 (FAM96B), Ciao1, and ANT2. MMS19, MIP18, and XPD localize to the mitotic spindle during mitosis. siRNA knockdown of MMS19, MIP18, or XPD causes improper chromosome segregation and accumulation of nuclei with abnormal shapes. XP-D and XP-D/CS patient cells also show increased frequency of abnormal mitosis.","method":"Protein complex purification/mass spectrometry, co-immunoprecipitation, siRNA knockdown, immunofluorescence localization during mitosis, analysis of patient cells","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — complex purification with MS identification, reciprocal validation, siRNA phenotype, and patient cell confirmation; multiple orthogonal methods","pmids":["20797633"],"is_preprint":false},{"year":2010,"finding":"Drosophila Xpd regulates Cdk7 (CAK) subcellular localization during mitosis: loss of Xpd causes mislocalization of Cdk7/CAK and altered local mitotic kinase activity, leading to defects in spindle dynamics, improper chromosome segregation, multipolar spindles, and aneuploidy. This function is independent of NER and transcription.","method":"Drosophila genetics (xpd loss-of-function in early embryos), live imaging, immunofluorescence of Cdk7 localization, kinase activity assays, chromosome segregation analysis","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic loss-of-function with direct localization imaging and kinase activity readout; NER/transcription independence established in transcription-free embryo system","pmids":["20300654"],"is_preprint":false},{"year":2011,"finding":"XPD generates ATP-stimulated, DNA-mediated redox signaling via its [4Fe-4S] cluster. Using DNA-modified electrodes, XPD shows a DNA-bound redox potential of ~80 mV vs. NHE, similar to base excision repair proteins. The redox signal increases with ATP hydrolysis and is substrate-dependent, reporting on DNA conformational changes associated with enzymatic function.","method":"DNA-modified electrochemical electrodes, redox signal measurement, ATP hydrolysis assay","journal":"Journal of the American Chemical Society","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro electrochemistry with novel method, single lab, no independent replication reported","pmids":["21939244"],"is_preprint":false},{"year":2011,"finding":"XPB and XPD helicases within TFIIH asymmetrically unwind dsDNA flanking DNA damage; XPD anchors the CAK kinase complex (cyclinH, MAT1, CDK7) to TFIIH, coordinating NER with transcription and cell cycle through CAK signaling. XPB acts as an ATPase/translocase to open DNA at the damage site, while XPD verifies damage identity.","method":"Structural biology review integrating crystal structures, NMR, and EM data with biochemical and cellular information; functional model synthesis","journal":"DNA repair","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — mechanistic model integrating multiple structural and biochemical studies from multiple labs, but this paper itself is a review/synthesis rather than primary experiment","pmids":["21571596"],"is_preprint":false},{"year":2014,"finding":"In TFIIH, XPD helicase activity (requiring DNA binding, ATPase, and 4Fe4S domain integrity) is exclusively devoted to NER and is dispensable for transcription initiation. The p44 subunit activates XPD by stimulating its ATPase activity. Mutations in the 4Fe4S cluster domain abolish NER without affecting transcriptional activity of TFIIH.","method":"Comparative biochemical analysis (in vitro and in vivo) of human and Chaetomium thermophilum XPD; ATPase assays, NER complementation assays, transcription assays, mutagenesis of 4Fe4S domain","journal":"PLoS biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro and in vivo assays with mutagenesis dissecting NER vs. transcription functions; multiple orthogonal methods in one rigorous study","pmids":["25268380"],"is_preprint":false},{"year":2014,"finding":"Somatic ERCC2 mutations in muscle-invasive urothelial carcinoma impair NER function: expression of representative ERCC2 tumor-derived mutants in an ERCC2-deficient cell line failed to rescue cisplatin sensitivity and UV sensitivity compared with wild-type ERCC2, demonstrating loss of normal ERCC2 function contributes to cisplatin sensitivity.","method":"Whole-exome sequencing of patient tumors, functional complementation of ERCC2-deficient cells with mutant vs. wild-type ERCC2, cisplatin and UV cytotoxicity assays","journal":"Cancer discovery","confidence":"High","confidence_rationale":"Tier 2 / Strong — functional complementation assays with multiple patient-derived mutants vs. wild-type in isogenic cell system, combined with clinical genomics","pmids":["25096233"],"is_preprint":false},{"year":2015,"finding":"XPD localizes to the inner membrane of mitochondria; oxidative stress enhances XPD recruitment into the mitochondrial compartment. Knockdown of XPD in U2OS cells or XPD-deficient fibroblasts increases mitochondrial ROS, elevates mtDNA common deletion levels, and reduces oxidative damage repair capacity in mtDNA. Immunoprecipitation-mass spectrometry identified TUFM (mitochondrial Tu translation elongation factor) as a physical interaction partner of XPD in mitochondria; TUFM knockdown phenocopies XPD deficiency for mtDNA damage.","method":"Subcellular fractionation/Western blot, immunofluorescence localization, siRNA knockdown, mtDNA common deletion assay, oxidative damage repair assay, immunoprecipitation-mass spectrometry","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization by fractionation with functional consequence, IP-MS identification of TUFM, single lab with multiple orthogonal methods","pmids":["25969448"],"is_preprint":false},{"year":2016,"finding":"DNA loading by XPD proceeds via initial tight ssDNA binding to helicase domain 2, followed by transient opening of the Arch–4FeS domain interface allowing access to a second binding site on helicase domain 1 that directs DNA through the pore. Crystal structure of Sulfolobus acidocaldiarius XPD lacking helicase domain 2 shows otherwise unperturbed architecture, emphasizing the stability of the Arch–4FeS interface.","method":"X-ray crystallography, chemical cross-linking, modified DNA substrates, biochemical binding assays","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure plus cross-linking and biochemical assays in single rigorous study defining loading mechanism","pmids":["26896802"],"is_preprint":false},{"year":2020,"finding":"The Arch domain of XPD interacts with MAT1 (a component of the CDK-activating kinase complex); mutagenesis of the Arch–MAT1 interface impairs both NER (by reducing helicase activity or disrupting XPD–XPG interaction) and RNA polymerase II phosphorylation/RNA synthesis, demonstrating the Arch domain is mechanistically essential for both NER and transcription within TFIIH.","method":"Crystal structure of XPD Arch domain with MAT1, mutagenesis of interface residues, NER complementation assay, XPD helicase assay, XPD–XPG interaction assay, RNA synthesis/RNAP II phosphorylation assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure combined with mutagenesis, multiple functional assays (NER, transcription, protein interactions) in one rigorous study","pmids":["32245994"],"is_preprint":false},{"year":2014,"finding":"Arsenic exposure leads to promoter hypomethylation of ERCC2 and ~2-fold overexpression of ERCC2 protein, but this overexpression causes increased association of Cdk7 with ERCC2 (demonstrated by immunoprecipitation/Western blot), resulting in decreased CAK activity (reduced Ser392-p53 phosphorylation) and impaired DNA repair despite higher ERCC2 levels.","method":"Bisulfite-methylation-specific PCR, immunoprecipitation/Western blot, in vitro CAK activity assay (p53 Ser392 phosphorylation), micronuclei assay","journal":"Metallomics","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — immunoprecipitation and in vitro kinase assay, single lab, human cohort + cell line validation","pmids":["24473091"],"is_preprint":false},{"year":1997,"finding":"Different mutations in the XPD/ERCC2 gene produce distinct clinical phenotypes (XP vs. TTD). Allele-specific yeast complementation assays showed that the same nucleotide change at certain positions can cause either XP or TTD depending on the second allele; null mutations at shared positions indicate that the phenotype is determined by the other (non-null) allele. Most TTD mutations cluster in a region (amino acids 713–730 and helicase motif areas) distinct from typical XP mutations.","method":"ERCC2 cDNA sequencing from patient cell lines, yeast complementation assay of individual alleles","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 2 / Strong — allele-specific complementation in yeast for multiple patient alleles; mechanistic placement of mutation sites to phenotype","pmids":["9238033"],"is_preprint":false},{"year":2006,"finding":"XPB (ERCC3) and XPD (ERCC2) play a principal role in the degradation of retroviral cDNA in the nucleus. XPB and XPD mutant cells exhibit increased transduction efficiency by HIV- and MLV-based retroviral vectors, increased total cDNA, integrated provirus, and 2-LTR circles. XPA mutant cells do not show this effect, placing the function specifically in XPB/XPD but not the broader NER pathway.","method":"Retroviral transduction assays in XPB/XPD/XPA mutant cell lines, quantitative PCR for cDNA/integration/2-LTR circles, reverse transcription inhibitor experiments","journal":"Proceedings of the National Academy of Sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function cell lines with defined phenotype, epistasis (XPA negative), multiple viral systems; single lab","pmids":["16537383"],"is_preprint":false},{"year":2022,"finding":"MD simulations of human XPD bound to ssDNA containing a (6-4)PP UV photoproduct identify key residues involved in damage verification: FeS domain residues R112, R196, H135, K128; Arch domain residues E377 and R380; and ATPase lobe 1 residues 215–221. Arch and ATPase lobe 1 domain movements relative to the FeS domain modulate DNA–residue interactions to discriminate damaged from undamaged nucleotides, leading to XPD stalling at the lesion.","method":"All-atom molecular dynamics simulations of human XPD with undamaged and 6-4PP-damaged ssDNA","journal":"Nucleic acids research","confidence":"Low","confidence_rationale":"Tier 4 / Weak — computational simulation only, no experimental validation of identified residues in this paper","pmids":["35713557"],"is_preprint":false},{"year":2003,"finding":"Insulin regulates XPD expression via the RAS-signaling and p70 S6 kinase pathways in CHO cells transfected with the human insulin receptor. The intracellular XPD protein level is under exclusive control of the RAS-dependent cascade in response to insulin. Short-term high glucose potentiates insulin-dependent XPD regulation and protects against glucose-induced DNA damage, while chronic high glucose impairs insulin's ability to regulate XPD, leading to accumulation of DNA damage.","method":"Signaling pathway inhibitor experiments (RAS, p70 S6 kinase), Western blot, qRT-PCR, comet assay in CHO cells with human insulin receptor","journal":"Molecular and cellular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — pathway dissection with pharmacological inhibitors and functional DNA damage readout, single lab","pmids":["12706296"],"is_preprint":false},{"year":2012,"finding":"XPD mutations are associated with abnormal TFIIH-dependent transactivation of nuclear receptor for vitamin D (VDR). Cells from TTD, XP, and XP/TTD patients with specific XPD mutation pairs showed reduced (5 patients) or elevated (1 patient) vitamin D stimulation ratios of CYP24 and osteopontin, demonstrating that XPD serves as a structural bridge between TFIIH core and the CAK complex to regulate nuclear receptor-mediated transcription.","method":"Nuclear receptor transactivation reporter assays (CYP24, osteopontin expression after vitamin D stimulation) in primary patient fibroblasts from XPD compound heterozygotes","journal":"European journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional transactivation assays in multiple patient-derived cell lines with defined mutations, multiple nuclear receptor targets","pmids":["23232694"],"is_preprint":false},{"year":2019,"finding":"XPD suppresses HCC cell proliferation and migration via regulation of miR-29a-3p expression. miR-29a-3p directly targets Mdm2 and PDGF-B (confirmed by dual-luciferase reporter assay), and XPD suppresses proliferation and migration of HCC cells through this XPD→miR-29a-3p→Mdm2/PDGF-B axis.","method":"Western blot, qRT-PCR, MTT proliferation assay, transwell migration assay, dual-luciferase reporter assay for miR-29a-3p targets","journal":"Cell & bioscience","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, overexpression/knockdown with cellular phenotype and reporter assay, mechanistic pathway proposed but not deeply validated","pmids":["30627419"],"is_preprint":false},{"year":2019,"finding":"XPD-mutated cell lines (XP, XP-D/CS, TTD) are sensitive to oxidative stress (photoactivated methylene blue and KBrO3). XP-D/CS and TTD cells have severely impaired repair capacity for oxidized lesions in plasmid DNA (host cell reactivation assay) and accumulate more DNA strand breaks after oxidative treatment than wild-type, with persistent γ-H2AX and S/G2 arrest, demonstrating XPD participates in repair of oxidatively-induced DNA lesions.","method":"Host cell reactivation assay, alkaline comet assay, γ-H2AX immunofluorescence, cell cycle analysis, survival assays in patient-derived XPD-mutated cell lines","journal":"Mutagenesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal assays in patient-derived cell lines with defined XPD mutations; single lab","pmids":["31348825"],"is_preprint":false},{"year":2023,"finding":"NOP2-mediated m5C methylation of XPD mRNA elevates XPD mRNA stability and expression. NOP2 overexpression in HCC cells enhances XPD expression by increasing m5C methylation of XPD mRNA, which inhibits proliferation, migration, and invasion of HCC cells in vitro.","method":"In vitro cell overexpression, m5C methylation assay, Western blot, proliferation/migration/invasion assays","journal":"Neoplasma","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, single method for m5C modification, limited mechanistic detail in abstract","pmids":["37498063"],"is_preprint":false}],"current_model":"ERCC2/XPD is an ATP-dependent 5'-to-3' DNA helicase with an essential iron-sulfur (4Fe-4S) cluster domain that functions as a core subunit of the TFIIH complex: within TFIIH it verifies and unwinds DNA at lesion sites during nucleotide excision repair (its helicase activity being exclusively devoted to NER), acts as a structural scaffold for transcription initiation without requiring its enzymatic activity, anchors the CDK-activating kinase (CAK: CDK7-cyclin H-MAT1) to TFIIH to coordinate NER with transcription and cell-cycle progression, and—through its Arch domain interaction with MAT1—regulates nuclear receptor-mediated transactivation; independently of TFIIH, XPD participates in chromosome segregation as part of the MMXD complex (with MMS19, MIP18, Ciao1, ANT2) at the mitotic spindle, localizes to mitochondria to protect mtDNA from oxidative damage, and contributes to p53-dependent apoptosis and retroviral cDNA degradation."},"narrative":{"mechanistic_narrative":"ERCC2/XPD is an ATP-dependent 5'-to-3' DNA helicase that functions as a core subunit of the RNA polymerase II transcription factor TFIIH, coordinating nucleotide excision repair (NER) with transcription [PMID:8194528, PMID:25268380]. Its catalytic core comprises two RecA-like helicase domains (HD1, HD2), an Arch domain, and an N-terminal [4Fe-4S] cluster domain coordinated by conserved cysteines that is strictly required for helicase activity [PMID:16973432, PMID:18510924, PMID:18510925]. Within TFIIH, XPD's helicase activity—dependent on DNA binding, ATPase function, and 4Fe-4S domain integrity, and stimulated by the p44 subunit—is devoted exclusively to NER and is dispensable for transcription initiation, where XPD instead acts as a structural scaffold [PMID:25268380]. During lesion processing XPD verifies damage identity while loading DNA through a pore via a tightly held Arch–4FeS interface and a transient opening that exposes a second DNA-binding site [PMID:26896802], and damage discrimination involves coordinated Arch, FeS, and ATPase-domain movements that stall XPD at lesions [PMID:35713557]. Through its Arch domain XPD anchors the CDK-activating kinase (CAK; CDK7–cyclin H–MAT1) to TFIIH, contacting MAT1 to link NER and transcription with cell-cycle and nuclear-receptor-mediated transactivation [PMID:32245994, PMID:23232694], and regulation of CAK localization and activity by XPD controls mitotic progression [PMID:12853965, PMID:20300654]. Independently of TFIIH, XPD assembles into the MMXD complex (MMS19, MIP18/FAM96B, Ciao1, ANT2) at the mitotic spindle to ensure proper chromosome segregation [PMID:20797633], localizes to mitochondria where it interacts with TUFM to protect mtDNA from oxidative damage [PMID:25969448], and acts in the p53-dependent apoptotic response to DNA damage [PMID:8675009]. Distinct XPD mutations produce the clinically distinct phenotypes xeroderma pigmentosum and trichothiodystrophy depending on the affected domain and the second allele [PMID:9238033], and loss-of-function somatic ERCC2 mutations in urothelial carcinoma impair NER and confer cisplatin sensitivity [PMID:25096233].","teleology":[{"year":1994,"claim":"Established that ERCC2/XPD is a functional subunit of TFIIH, physically linking it to both NER and RNA polymerase II transcription and explaining why a repair gene also affects transcription.","evidence":"Co-purification, reciprocal immunoprecipitation, and transcription reconstitution of ERCC2 with BTF2/TFIIH","pmids":["8194528"],"confidence":"High","gaps":["Did not resolve the catalytic mechanism within TFIIH","Did not separate transcription vs. repair contributions"]},{"year":1996,"claim":"Placed XPD specifically in the p53-dependent apoptotic pathway downstream of p53 and upstream of caspases, distinguishing it from other XP factors.","evidence":"p53 microinjection and genetic complementation with wild-type XPD in patient fibroblasts, with epistasis across XP complementation groups","pmids":["8675009"],"confidence":"High","gaps":["Molecular mechanism linking XPD to p53 apoptosis not defined","Whether this depends on helicase or TFIIH function unknown"]},{"year":1997,"claim":"Showed that distinct XPD mutations cause distinct clinical syndromes (XP vs. TTD) and that phenotype is allele-dependent, framing XPD as a gene where mutation position dictates which TFIIH function is compromised.","evidence":"Patient cDNA sequencing and allele-specific yeast complementation","pmids":["9238033"],"confidence":"High","gaps":["Structural basis of XP vs. TTD mutation effects not yet known","Mechanism of allele interaction unexplained"]},{"year":2003,"claim":"Revealed that XPD negatively regulates CAK activity and is downregulated at mitotic onset, connecting XPD dosage to cell-cycle progression beyond its repair role.","evidence":"Drosophila gain- and loss-of-function genetics with Cdk T-loop phosphorylation readouts; insulin/RAS-pathway regulation of XPD levels shown separately in CHO cells","pmids":["12853965","12706296"],"confidence":"High","gaps":["Direct biochemical mechanism of CAK inhibition by XPD not resolved","Mammalian relevance of mitotic downregulation untested"]},{"year":2006,"claim":"Defined the [4Fe-4S] cluster domain as essential for helicase activity and NER, and revealed an unexpected TFIIH-linked role in degrading retroviral cDNA distinct from canonical NER.","evidence":"Fe-S cluster characterization, cysteine mutagenesis and helicase assays with yeast UV-repair complementation; retroviral transduction assays in XPB/XPD/XPA mutant cells","pmids":["16973432","16537383"],"confidence":"Medium","gaps":["How the Fe-S cluster contributes mechanically to unwinding not fully defined","Mechanism of retroviral cDNA degradation by XPB/XPD unknown"]},{"year":2008,"claim":"Provided the structural framework: a four-domain catalytic core (HD1, HD2, 4FeS, Arch) with 5'-to-3' polarity, mapping disease mutations to functional regions and explaining XP, XP/CS, and TTD phenotypes.","evidence":"Two independent X-ray crystal structures of archaeal XPD with biochemical helicase assays and disease-mutation mapping","pmids":["18510924","18510925"],"confidence":"High","gaps":["Structures are archaeal, not human TFIIH-bound","Dynamic conformational changes during catalysis not captured"]},{"year":2010,"claim":"Identified a TFIIH-independent function for XPD in chromosome segregation through the MMXD complex at the mitotic spindle, broadening XPD's role beyond repair and transcription.","evidence":"MMXD complex purification/MS, reciprocal Co-IP, siRNA segregation phenotypes, and patient-cell analysis; Drosophila imaging of Cdk7/CAK mislocalization upon Xpd loss","pmids":["20797633","20300654"],"confidence":"High","gaps":["Direct molecular role of XPD within MMXD at the spindle unclear","How XPD partitions between TFIIH and MMXD not defined"]},{"year":2011,"claim":"Linked the 4Fe-4S cluster to ATP-stimulated DNA-mediated redox signaling and synthesized a mechanistic model of asymmetric DNA unwinding with XPD as the damage-verification helicase anchoring CAK.","evidence":"DNA-modified electrochemistry of XPD redox potential; structural-biochemical review synthesizing the XPB/XPD unwinding model","pmids":["21939244","21571596"],"confidence":"Medium","gaps":["Redox signaling shown in vitro only, no independent replication","Physiological role of redox signaling untested in cells"]},{"year":2014,"claim":"Cleanly separated XPD's helicase function (exclusively for NER, p44-stimulated) from its scaffolding role in transcription, and demonstrated that loss-of-function ERCC2 mutations in urothelial cancer drive cisplatin sensitivity.","evidence":"Comparative biochemistry/mutagenesis of human and C. thermophilum XPD; functional complementation of tumor-derived ERCC2 mutants in ERCC2-deficient cells; arsenic-induced ERCC2 dysregulation via Cdk7 association","pmids":["25268380","25096233","24473091"],"confidence":"High","gaps":["How transcription proceeds without XPD catalytic activity not fully detailed","In vivo predictive value of cancer mutations for therapy response not established here"]},{"year":2015,"claim":"Demonstrated a mitochondrial role: XPD localizes to the inner mitochondrial membrane, interacts with TUFM, and protects mtDNA from oxidative damage, extending XPD function beyond the nucleus.","evidence":"Subcellular fractionation, immunofluorescence, siRNA, mtDNA deletion and oxidative-repair assays, and IP-MS identifying TUFM","pmids":["25969448"],"confidence":"Medium","gaps":["Catalytic mechanism of XPD in mtDNA protection unknown","Functional significance of TUFM interaction not mechanistically resolved"]},{"year":2016,"claim":"Resolved the DNA loading mechanism, showing sequential engagement of HD2 then transient Arch–4FeS opening to thread DNA through the pore onto HD1.","evidence":"Crystal structure of HD2-deleted archaeal XPD with cross-linking and biochemical DNA-binding assays","pmids":["26896802"],"confidence":"High","gaps":["Loading kinetics in the context of full TFIIH not addressed","Coupling to XPB translocation not resolved"]},{"year":2020,"claim":"Established the Arch domain–MAT1 interaction as mechanistically essential for both NER and transcription, unifying XPD's dual roles through a single structural interface.","evidence":"Crystal structure of the XPD Arch–MAT1 complex with interface mutagenesis and NER, helicase, XPD–XPG interaction, and RNAP II phosphorylation assays","pmids":["32245994"],"confidence":"High","gaps":["How CAK release/retention is dynamically regulated during repair not defined","Link to nuclear-receptor transactivation only indirectly addressed"]},{"year":2022,"claim":"Proposed atomic-level residues and domain motions underlying damage verification and lesion-induced stalling of human XPD.","evidence":"All-atom molecular dynamics simulations of human XPD with undamaged and 6-4PP-containing ssDNA","pmids":["35713557"],"confidence":"Low","gaps":["Computational only — identified residues not experimentally validated in this study","Predicted dynamics not confirmed structurally or biochemically"]},{"year":null,"claim":"It remains unresolved how XPD dynamically partitions among its TFIIH, MMXD, mitochondrial, and apoptotic functions, and how upstream signals regulate XPD abundance and localization to coordinate these roles.","evidence":"No single study in the corpus integrates XPD's multiple complexes and regulatory inputs","pmids":[],"confidence":"Low","gaps":["Mechanism partitioning XPD between TFIIH and MMXD unknown","Regulation of mitochondrial recruitment incompletely defined","Cancer-relevant signaling control of XPD levels not mechanistically unified"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[3,4,5,10]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[4,5,13]},{"term_id":"GO:0140097","term_label":"catalytic activity, acting on DNA","supporting_discovery_ids":[3,5,10,13]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[10]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[9,14]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[2,14]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,17]},{"term_id":"GO:0005815","term_label":"microtubule organizing center","supporting_discovery_ids":[6,7]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[12]}],"pathway":[{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[0,10,11]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,10,14,20]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[2,6,7]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[1]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[11,16]}],"complexes":["TFIIH","MMXD complex","CAK (CDK7-cyclin H-MAT1)"],"partners":["ERCC3","GTF2H1","MAT1","CDK7","MMS19","FAM96B","CIAO1","TUFM"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P18074","full_name":"General transcription and DNA repair factor IIH helicase subunit XPD","aliases":["Basic transcription factor 2 80 kDa subunit","BTF2 p80","CXPD","DNA 5'-3' helicase XPD","DNA excision repair protein ERCC-2","DNA repair protein complementing XP-D cells","TFIIH basal transcription factor complex 80 kDa subunit","TFIIH 80 kDa subunit","TFIIH p80","Xeroderma pigmentosum group D-complementing protein"],"length_aa":760,"mass_kda":86.9,"function":"ATP-dependent 5'-3' DNA helicase (PubMed:31253769, PubMed:8413672, PubMed:9771713). Component of the general transcription and DNA repair factor IIH (TFIIH) core complex, not absolutely essential for minimal transcription in vitro (PubMed:10024882, PubMed:17466626, PubMed:9771713). Required for transcription-coupled nucleotide excision repair (NER) of damaged DNA; recognizes damaged bases (PubMed:17466626, PubMed:23352696, PubMed:9771713). Sequestered in chromatin on UV-damaged DNA (PubMed:23352696). When complexed to CDK-activating kinase (CAK), involved in transcription by RNA polymerase II. In NER, TFIIH acts by opening DNA around the lesion to allow the excision of the damaged oligonucleotide and its replacement by a new DNA fragment. The ATP-dependent helicase activity of XPD/ERCC2 is required for DNA opening. Involved in DNA lesion verification (PubMed:31253769). In transcription, TFIIH has an essential role in transcription initiation. When the pre-initiation complex (PIC) has been established, TFIIH is required for promoter opening and promoter escape. Phosphorylation of the C-terminal tail (CTD) of the largest subunit of RNA polymerase II by the kinase module CAK controls the initiation of transcription. XPD/ERCC2 acts by forming a bridge between CAK and the core-TFIIH complex. The structure of the TFIIH transcription complex differs from the NER-TFIIH complex; large movements by XPD/ERCC2 and XPB/ERCC3 are stabilized by XPA which allow this subunit to contact ssDNA (PubMed:31253769, PubMed:33902107). Involved in the regulation of vitamin-D receptor activity. As part of the mitotic spindle-associated MMXD complex it plays a role in chromosome segregation. Might have a role in aging process and could play a causative role in the generation of skin cancers","subcellular_location":"Nucleus; Cytoplasm, cytoskeleton, spindle","url":"https://www.uniprot.org/uniprotkb/P18074/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/ERCC2","classification":"Common Essential","n_dependent_lines":1145,"n_total_lines":1208,"dependency_fraction":0.9478476821192053},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CDC7","stoichiometry":10.0},{"gene":"CDK7","stoichiometry":10.0},{"gene":"CETN2","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/ERCC2","total_profiled":1310},"omim":[{"mim_id":"614778","title":"CYTOSOLIC IRON-SULFUR ASSEMBLY COMPONENT 2B; CIAO2B","url":"https://www.omim.org/entry/614778"},{"mim_id":"614777","title":"MMS19 HOMOLOG, CYTOSOLIC IRON-SULFUR ASSEMBLY COMPONENT; MMS19","url":"https://www.omim.org/entry/614777"},{"mim_id":"614108","title":"BPI FOLD-CONTAINING PROTEIN, FAMILY B, MEMBER 2; BPIFB2","url":"https://www.omim.org/entry/614108"},{"mim_id":"613644","title":"ACTIVATING TRANSCRIPTION FACTOR 7-INTERACTING PROTEIN; ATF7IP","url":"https://www.omim.org/entry/613644"},{"mim_id":"611153","title":"XPA, DNA DAMAGE RECOGNITION AND REPAIR FACTOR; XPA","url":"https://www.omim.org/entry/611153"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/ERCC2"},"hgnc":{"alias_symbol":["MAG","EM9","MGC102762","MGC126218","MGC126219"],"prev_symbol":["XPD"]},"alphafold":{"accession":"P18074","domains":[{"cath_id":"-","chopping":"249-440","consensus_level":"high","plddt":82.5047,"start":249,"end":440},{"cath_id":"3.40.50.300","chopping":"491-728","consensus_level":"high","plddt":90.0688,"start":491,"end":728}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P18074","model_url":"https://alphafold.ebi.ac.uk/files/AF-P18074-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P18074-F1-predicted_aligned_error_v6.png","plddt_mean":87.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ERCC2","jax_strain_url":"https://www.jax.org/strain/search?query=ERCC2"},"sequence":{"accession":"P18074","fasta_url":"https://rest.uniprot.org/uniprotkb/P18074.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P18074/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P18074"}},"corpus_meta":[{"pmid":"25096233","id":"PMC_25096233","title":"Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma.","date":"2014","source":"Cancer discovery","url":"https://pubmed.ncbi.nlm.nih.gov/25096233","citation_count":514,"is_preprint":false},{"pmid":"11532866","id":"PMC_11532866","title":"XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects.","date":"2001","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/11532866","citation_count":404,"is_preprint":false},{"pmid":"10753184","id":"PMC_10753184","title":"XPD polymorphisms: effects on DNA repair proficiency.","date":"2000","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/10753184","citation_count":373,"is_preprint":false},{"pmid":"8194528","id":"PMC_8194528","title":"The ERCC2/DNA repair protein is associated with the class II BTF2/TFIIH transcription factor.","date":"1994","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/8194528","citation_count":342,"is_preprint":false},{"pmid":"18510924","id":"PMC_18510924","title":"XPD helicase structures and activities: insights into the cancer and aging phenotypes from XPD mutations.","date":"2008","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/18510924","citation_count":311,"is_preprint":false},{"pmid":"8675009","id":"PMC_8675009","title":"The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway.","date":"1996","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/8675009","citation_count":303,"is_preprint":false},{"pmid":"1433335","id":"PMC_1433335","title":"ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients.","date":"1992","source":"Journal of the National Cancer Institute","url":"https://pubmed.ncbi.nlm.nih.gov/1433335","citation_count":289,"is_preprint":false},{"pmid":"16973432","id":"PMC_16973432","title":"The DNA repair helicases XPD and FancJ have essential iron-sulfur domains.","date":"2006","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/16973432","citation_count":277,"is_preprint":false},{"pmid":"9238033","id":"PMC_9238033","title":"Xeroderma pigmentosum and trichothiodystrophy are associated with different mutations in the XPD (ERCC2) repair/transcription gene.","date":"1997","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9238033","citation_count":233,"is_preprint":false},{"pmid":"18510925","id":"PMC_18510925","title":"Structure of the DNA repair helicase XPD.","date":"2008","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/18510925","citation_count":220,"is_preprint":false},{"pmid":"12435843","id":"PMC_12435843","title":"ERCC2/XPD gene polymorphisms and cancer risk.","date":"2002","source":"Mutagenesis","url":"https://pubmed.ncbi.nlm.nih.gov/12435843","citation_count":189,"is_preprint":false},{"pmid":"11133811","id":"PMC_11133811","title":"XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis.","date":"2000","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/11133811","citation_count":174,"is_preprint":false},{"pmid":"16707649","id":"PMC_16707649","title":"XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review.","date":"2006","source":"American journal of epidemiology","url":"https://pubmed.ncbi.nlm.nih.gov/16707649","citation_count":166,"is_preprint":false},{"pmid":"12692111","id":"PMC_12692111","title":"Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk.","date":"2003","source":"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/12692111","citation_count":160,"is_preprint":false},{"pmid":"15615908","id":"PMC_15615908","title":"ERCC2 /XPD gene polymorphisms and lung cancer: a HuGE review.","date":"2005","source":"American journal of epidemiology","url":"https://pubmed.ncbi.nlm.nih.gov/15615908","citation_count":147,"is_preprint":false},{"pmid":"21571596","id":"PMC_21571596","title":"XPB and XPD helicases in TFIIH orchestrate DNA duplex opening and damage verification to coordinate repair with transcription and cell cycle via CAK kinase.","date":"2011","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/21571596","citation_count":142,"is_preprint":false},{"pmid":"11238179","id":"PMC_11238179","title":"Nucleotide excision repair gene XPD polymorphisms and genetic predisposition to melanoma.","date":"2001","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/11238179","citation_count":118,"is_preprint":false},{"pmid":"14744728","id":"PMC_14744728","title":"DNA repair gene XRCC1 and XPD polymorphisms and risk of prostate cancer.","date":"2004","source":"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/14744728","citation_count":112,"is_preprint":false},{"pmid":"12853965","id":"PMC_12853965","title":"Xpd/Ercc2 regulates CAK activity and mitotic progression.","date":"2003","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/12853965","citation_count":106,"is_preprint":false},{"pmid":"20797633","id":"PMC_20797633","title":"MMXD, a TFIIH-independent XPD-MMS19 protein complex involved in chromosome segregation.","date":"2010","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/20797633","citation_count":104,"is_preprint":false},{"pmid":"8571952","id":"PMC_8571952","title":"Defects in the DNA repair and transcription gene ERCC2(XPD) in trichothiodystrophy.","date":"1996","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8571952","citation_count":96,"is_preprint":false},{"pmid":"12220217","id":"PMC_12220217","title":"DNA repair gene ERCC1 and ERCC2/XPD polymorphisms and risk of squamous cell carcinoma of the head and neck.","date":"2002","source":"Archives of otolaryngology--head & neck surgery","url":"https://pubmed.ncbi.nlm.nih.gov/12220217","citation_count":94,"is_preprint":false},{"pmid":"16054878","id":"PMC_16054878","title":"Polymorphisms in the human XPD (ERCC2) gene, DNA repair capacity and cancer susceptibility: an appraisal.","date":"2005","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/16054878","citation_count":92,"is_preprint":false},{"pmid":"25268380","id":"PMC_25268380","title":"In TFIIH, XPD helicase is exclusively devoted to DNA repair.","date":"2014","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/25268380","citation_count":76,"is_preprint":false},{"pmid":"11470747","id":"PMC_11470747","title":"XPD exon 10 and 23 polymorphisms and DNA repair in human skin in situ.","date":"2001","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/11470747","citation_count":76,"is_preprint":false},{"pmid":"15364127","id":"PMC_15364127","title":"DNA repair gene XPD polymorphism and lung cancer risk: a meta-analysis.","date":"2004","source":"Lung cancer (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/15364127","citation_count":71,"is_preprint":false},{"pmid":"15941969","id":"PMC_15941969","title":"Genetic variation in XPD, sun exposure, and risk of skin cancer.","date":"2005","source":"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/15941969","citation_count":68,"is_preprint":false},{"pmid":"16195314","id":"PMC_16195314","title":"Uranyl acetate induces hprt mutations and uranium-DNA adducts in Chinese hamster ovary EM9 cells.","date":"2005","source":"Mutagenesis","url":"https://pubmed.ncbi.nlm.nih.gov/16195314","citation_count":65,"is_preprint":false},{"pmid":"16212814","id":"PMC_16212814","title":"ERCC1 and ERCC2 polymorphisms and adult glioma.","date":"2005","source":"Neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/16212814","citation_count":63,"is_preprint":false},{"pmid":"1372108","id":"PMC_1372108","title":"The XPD complementation group. Insights into xeroderma pigmentosum, Cockayne's syndrome and trichothiodystrophy.","date":"1992","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/1372108","citation_count":63,"is_preprint":false},{"pmid":"6843572","id":"PMC_6843572","title":"The relationship between sister-chromatid exchange and perturbations in DNA replication in mutant EM9 and normal CHO cells.","date":"1983","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/6843572","citation_count":62,"is_preprint":false},{"pmid":"20016270","id":"PMC_20016270","title":"The long unwinding road: XPB and XPD helicases in damaged DNA opening.","date":"2010","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/20016270","citation_count":56,"is_preprint":false},{"pmid":"16537383","id":"PMC_16537383","title":"The DNA repair genes XPB and XPD defend cells from retroviral infection.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16537383","citation_count":56,"is_preprint":false},{"pmid":"15834925","id":"PMC_15834925","title":"Polymorphisms in GLTSCR1 and ERCC2 are associated with the development of oligodendrogliomas.","date":"2005","source":"Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/15834925","citation_count":56,"is_preprint":false},{"pmid":"30520735","id":"PMC_30520735","title":"DNA translocation mechanism of an XPD family helicase.","date":"2018","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/30520735","citation_count":55,"is_preprint":false},{"pmid":"19101034","id":"PMC_19101034","title":"DNA repair gene XPD and XRCC1 polymorphisms and the risk of childhood acute lymphoblastic leukemia.","date":"2008","source":"Leukemia research","url":"https://pubmed.ncbi.nlm.nih.gov/19101034","citation_count":53,"is_preprint":false},{"pmid":"14735199","id":"PMC_14735199","title":"XPD gene polymorphism and host characteristics in the association with cutaneous malignant melanoma risk.","date":"2004","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/14735199","citation_count":53,"is_preprint":false},{"pmid":"25969448","id":"PMC_25969448","title":"XPD localizes in mitochondria and protects the mitochondrial genome from oxidative DNA damage.","date":"2015","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/25969448","citation_count":52,"is_preprint":false},{"pmid":"7510367","id":"PMC_7510367","title":"Altered DNA ligase III activity in the CHO EM9 mutant.","date":"1994","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/7510367","citation_count":51,"is_preprint":false},{"pmid":"6738565","id":"PMC_6738565","title":"DNA-ligase activities appear normal in the CHO mutant EM9.","date":"1984","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/6738565","citation_count":51,"is_preprint":false},{"pmid":"27262611","id":"PMC_27262611","title":"Role of XPD in cellular functions: To TFIIH and beyond.","date":"2016","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/27262611","citation_count":50,"is_preprint":false},{"pmid":"17264068","id":"PMC_17264068","title":"XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk.","date":"2007","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/17264068","citation_count":50,"is_preprint":false},{"pmid":"16492913","id":"PMC_16492913","title":"Variation in DNA repair genes ERCC2, XRCC1, and XRCC3 and risk of follicular lymphoma.","date":"2006","source":"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/16492913","citation_count":50,"is_preprint":false},{"pmid":"21939244","id":"PMC_21939244","title":"ATP-stimulated, DNA-mediated redox signaling by XPD, a DNA repair and transcription helicase.","date":"2011","source":"Journal of the American Chemical Society","url":"https://pubmed.ncbi.nlm.nih.gov/21939244","citation_count":49,"is_preprint":false},{"pmid":"15564288","id":"PMC_15564288","title":"Polymorphisms in XPD and TP53 and mutation in human lung cancer.","date":"2004","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/15564288","citation_count":48,"is_preprint":false},{"pmid":"9739812","id":"PMC_9739812","title":"The CHO XRCC1 mutant, EM9, deficient in DNA ligase III activity, exhibits hypersensitivity to camptothecin independent of DNA replication.","date":"1998","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/9739812","citation_count":47,"is_preprint":false},{"pmid":"20651612","id":"PMC_20651612","title":"ERCC2/XPD Lys751Gln and Asp312Asn gene polymorphism and lung cancer risk: a meta-analysis involving 22 case-control studies.","date":"2010","source":"Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/20651612","citation_count":46,"is_preprint":false},{"pmid":"7849702","id":"PMC_7849702","title":"Structural and mutational analysis of the xeroderma pigmentosum group D (XPD) gene.","date":"1994","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/7849702","citation_count":42,"is_preprint":false},{"pmid":"15199548","id":"PMC_15199548","title":"Effect of XPD/ERCC2 polymorphisms on chromosome aberration frequencies in smokers and on sensitivity to the mutagenic tobacco-specific nitrosamine NNK.","date":"2004","source":"Environmental and molecular mutagenesis","url":"https://pubmed.ncbi.nlm.nih.gov/15199548","citation_count":41,"is_preprint":false},{"pmid":"24473091","id":"PMC_24473091","title":"Arsenic-induced promoter hypomethylation and over-expression of ERCC2 reduces DNA repair capacity in humans by non-disjunction of the ERCC2-Cdk7 complex.","date":"2014","source":"Metallomics : integrated biometal science","url":"https://pubmed.ncbi.nlm.nih.gov/24473091","citation_count":41,"is_preprint":false},{"pmid":"1408759","id":"PMC_1408759","title":"Construction of human XRCC1 minigenes that fully correct the CHO DNA repair mutant EM9.","date":"1992","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/1408759","citation_count":41,"is_preprint":false},{"pmid":"21087650","id":"PMC_21087650","title":"Genotoxic and apoptotic activities of the food flavourings myristicin and eugenol in AA8 and XRCC1 deficient EM9 cells.","date":"2010","source":"Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association","url":"https://pubmed.ncbi.nlm.nih.gov/21087650","citation_count":40,"is_preprint":false},{"pmid":"20379847","id":"PMC_20379847","title":"Meta-analysis of two ERCC2 (XPD) polymorphisms, Asp312Asn and Lys751Gln, in breast cancer.","date":"2010","source":"Breast cancer research and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/20379847","citation_count":40,"is_preprint":false},{"pmid":"16685590","id":"PMC_16685590","title":"XPD common variants and their association with melanoma and breast cancer risk.","date":"2006","source":"Breast cancer research and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/16685590","citation_count":40,"is_preprint":false},{"pmid":"19109787","id":"PMC_19109787","title":"Polymorphisms of DNA repair genes: ADPRT, XRCC1, and XPD and cancer risk in genetic epidemiology.","date":"2009","source":"Methods in molecular biology (Clifton, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/19109787","citation_count":39,"is_preprint":false},{"pmid":"26896802","id":"PMC_26896802","title":"Mechanism of DNA loading by the DNA repair helicase XPD.","date":"2016","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/26896802","citation_count":39,"is_preprint":false},{"pmid":"15381366","id":"PMC_15381366","title":"Polymorphisms in the DNA repair gene XPD and susceptibility to esophageal squamous cell carcinoma.","date":"2004","source":"Cancer genetics and cytogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/15381366","citation_count":39,"is_preprint":false},{"pmid":"17637462","id":"PMC_17637462","title":"Polymorphisms of DNA repair genes XPD and XRCC1 and risk of cataract development.","date":"2007","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/17637462","citation_count":39,"is_preprint":false},{"pmid":"3115605","id":"PMC_3115605","title":"Induction and repair of DNA single-strand breaks in EM9 mutant CHO cells treated with hydrogen peroxide.","date":"1987","source":"Chemico-biological interactions","url":"https://pubmed.ncbi.nlm.nih.gov/3115605","citation_count":38,"is_preprint":false},{"pmid":"32245994","id":"PMC_32245994","title":"In TFIIH the Arch domain of XPD is mechanistically essential for transcription and DNA repair.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/32245994","citation_count":38,"is_preprint":false},{"pmid":"20300654","id":"PMC_20300654","title":"Drosophila Xpd regulates Cdk7 localization, mitotic kinase activity, spindle dynamics, and chromosome segregation.","date":"2010","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20300654","citation_count":35,"is_preprint":false},{"pmid":"24023723","id":"PMC_24023723","title":"ERCC1 and ERCC2 variants predict survival in gastric cancer patients.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24023723","citation_count":35,"is_preprint":false},{"pmid":"18616887","id":"PMC_18616887","title":"ERCC1 and ERCC2 polymorphisms and risk of idiopathic azoospermia in a Chinese population.","date":"2008","source":"Reproductive biomedicine online","url":"https://pubmed.ncbi.nlm.nih.gov/18616887","citation_count":33,"is_preprint":false},{"pmid":"7563073","id":"PMC_7563073","title":"Characteristics of UV-induced mutation spectra in human XP-D/ERCC2 gene-mutated xeroderma pigmentosum and trichothiodystrophy cells.","date":"1995","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/7563073","citation_count":33,"is_preprint":false},{"pmid":"15896456","id":"PMC_15896456","title":"The DNA repair gene ERCC2/XPD polymorphism Arg 156Arg (A22541C) and risk of lung cancer in a Chinese population.","date":"2004","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/15896456","citation_count":33,"is_preprint":false},{"pmid":"6510115","id":"PMC_6510115","title":"Bloom's syndrome and EM9 cells in BrdU-containing medium exhibit similarly elevated frequencies of sister chromatid exchange but dissimilar amounts of cellular proliferation and chromosome disruption.","date":"1984","source":"Chromosoma","url":"https://pubmed.ncbi.nlm.nih.gov/6510115","citation_count":32,"is_preprint":false},{"pmid":"21245954","id":"PMC_21245954","title":"Polymorphisms in two DNA repair genes (XPD and XRCC1)--association with age related cataracts.","date":"2011","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/21245954","citation_count":32,"is_preprint":false},{"pmid":"12749816","id":"PMC_12749816","title":"DNA repair gene XPD and susceptibility to arsenic-induced hyperkeratosis.","date":"2003","source":"Toxicology letters","url":"https://pubmed.ncbi.nlm.nih.gov/12749816","citation_count":31,"is_preprint":false},{"pmid":"18692601","id":"PMC_18692601","title":"XPD structure reveals its secrets.","date":"2008","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/18692601","citation_count":30,"is_preprint":false},{"pmid":"18196582","id":"PMC_18196582","title":"Polymorphisms in XPC and ERCC2 genes, smoking and breast cancer risk.","date":"2008","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/18196582","citation_count":30,"is_preprint":false},{"pmid":"30627419","id":"PMC_30627419","title":"XPD suppresses cell proliferation and migration via miR-29a-3p-Mdm2/PDGF-B axis in HCC.","date":"2019","source":"Cell & bioscience","url":"https://pubmed.ncbi.nlm.nih.gov/30627419","citation_count":28,"is_preprint":false},{"pmid":"22496165","id":"PMC_22496165","title":"A polymorphism in the XPD gene predisposes to leukemic transformation and new nonmyeloid malignancies in essential thrombocythemia and polycythemia vera.","date":"2012","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/22496165","citation_count":28,"is_preprint":false},{"pmid":"7688089","id":"PMC_7688089","title":"Cytogenetic effects of inhibition of topoisomerase I or II activities in the CHO mutant EM9 and its parental line AA8.","date":"1993","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/7688089","citation_count":27,"is_preprint":false},{"pmid":"1796118","id":"PMC_1796118","title":"Repair of near-visible- and blue-light-induced DNA single-strand breaks by the CHO cell lines AA8 and EM9.","date":"1991","source":"Photochemistry and photobiology","url":"https://pubmed.ncbi.nlm.nih.gov/1796118","citation_count":26,"is_preprint":false},{"pmid":"25951169","id":"PMC_25951169","title":"New mutation in the mouse Xpd/Ercc2 gene leads to recessive cataracts.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25951169","citation_count":25,"is_preprint":false},{"pmid":"19492231","id":"PMC_19492231","title":"XPD polymorphisms, cigarette smoking, and bladder cancer risk: a meta-analysis.","date":"2009","source":"Journal of toxicology and environmental health. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/19492231","citation_count":25,"is_preprint":false},{"pmid":"21614524","id":"PMC_21614524","title":"Association of ERCC2/XPD polymorphisms and interaction with tobacco smoking in lung cancer susceptibility: a systemic review and meta-analysis.","date":"2011","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/21614524","citation_count":25,"is_preprint":false},{"pmid":"28489582","id":"PMC_28489582","title":"Association between the ERCC2 Asp312Asn polymorphism and risk of cancer.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28489582","citation_count":24,"is_preprint":false},{"pmid":"25209371","id":"PMC_25209371","title":"Potentially functional polymorphisms in the ERCC2 gene and risk of esophageal squamous cell carcinoma in Chinese populations.","date":"2014","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/25209371","citation_count":23,"is_preprint":false},{"pmid":"37498063","id":"PMC_37498063","title":"NOP2-mediated m5C methylation of XPD is associated with hepatocellular carcinoma progression.","date":"2023","source":"Neoplasma","url":"https://pubmed.ncbi.nlm.nih.gov/37498063","citation_count":23,"is_preprint":false},{"pmid":"24101192","id":"PMC_24101192","title":"XPD Asp312Asn and Lys751Gln polymorphisms and breast cancer susceptibility: a meta-analysis.","date":"2013","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24101192","citation_count":22,"is_preprint":false},{"pmid":"25113251","id":"PMC_25113251","title":"Association between the XPD/ERCC2 Lys751Gln polymorphism and risk of cancer: evidence from 224 case-control studies.","date":"2014","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25113251","citation_count":22,"is_preprint":false},{"pmid":"23232694","id":"PMC_23232694","title":"Abnormal XPD-induced nuclear receptor transactivation in DNA repair disorders: trichothiodystrophy and xeroderma pigmentosum.","date":"2012","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/23232694","citation_count":21,"is_preprint":false},{"pmid":"19592152","id":"PMC_19592152","title":"Genetic polymorphisms in DNA repair gene APE1, XRCC1 and XPD and the risk of pre-eclampsia.","date":"2009","source":"European journal of obstetrics, gynecology, and reproductive biology","url":"https://pubmed.ncbi.nlm.nih.gov/19592152","citation_count":21,"is_preprint":false},{"pmid":"19736055","id":"PMC_19736055","title":"Polymorphisms in the nucleotide excision repair gene ERCC2/XPD and risk of non-Hodgkin lymphoma.","date":"2009","source":"Cancer epidemiology","url":"https://pubmed.ncbi.nlm.nih.gov/19736055","citation_count":21,"is_preprint":false},{"pmid":"2716763","id":"PMC_2716763","title":"Mutagen-induced recombination between stably integrated neo gene fragments in CHO and EM9 cells.","date":"1989","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/2716763","citation_count":20,"is_preprint":false},{"pmid":"21643959","id":"PMC_21643959","title":"Impact of DNA repair genes polymorphism (XPD and XRCC1) on the risk of breast cancer in Egyptian female patients.","date":"2011","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/21643959","citation_count":20,"is_preprint":false},{"pmid":"24906341","id":"PMC_24906341","title":"Association between DNA repair genes (XPD and XRCC1) polymorphisms and susceptibility to age-related cataract (ARC): a meta-analysis.","date":"2014","source":"Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie","url":"https://pubmed.ncbi.nlm.nih.gov/24906341","citation_count":18,"is_preprint":false},{"pmid":"35713557","id":"PMC_35713557","title":"Mechanism of lesion verification by the human XPD helicase in nucleotide excision repair.","date":"2022","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/35713557","citation_count":18,"is_preprint":false},{"pmid":"12706296","id":"PMC_12706296","title":"Insulin and glucose regulate the expression of the DNA repair enzyme XPD.","date":"2003","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/12706296","citation_count":18,"is_preprint":false},{"pmid":"31348825","id":"PMC_31348825","title":"XPD/ERCC2 mutations interfere in cellular responses to oxidative stress.","date":"2019","source":"Mutagenesis","url":"https://pubmed.ncbi.nlm.nih.gov/31348825","citation_count":17,"is_preprint":false},{"pmid":"22994751","id":"PMC_22994751","title":"Association between XPD Asp312Asn polymorphism and esophageal cancer susceptibility: a meta-analysis.","date":"2012","source":"Asian Pacific journal of cancer prevention : APJCP","url":"https://pubmed.ncbi.nlm.nih.gov/22994751","citation_count":17,"is_preprint":false},{"pmid":"2029744","id":"PMC_2029744","title":"Characterization of revertants of the CHO EM9 mutant arising during DNA transfection.","date":"1991","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/2029744","citation_count":17,"is_preprint":false},{"pmid":"19707883","id":"PMC_19707883","title":"Decreased expression and the Lys751Gln polymorphism of the XPD gene are associated with extreme longevity.","date":"2009","source":"Biogerontology","url":"https://pubmed.ncbi.nlm.nih.gov/19707883","citation_count":17,"is_preprint":false},{"pmid":"22179996","id":"PMC_22179996","title":"Association between XPD Lys751Gln polymorphism and risk of head and neck cancer: a meta-analysis.","date":"2011","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/22179996","citation_count":17,"is_preprint":false},{"pmid":"23593158","id":"PMC_23593158","title":"ERCC1 and ERCC2 haplotype modulates induced BPDE-DNA adducts in primary cultured lymphocytes.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23593158","citation_count":17,"is_preprint":false},{"pmid":"15650764","id":"PMC_15650764","title":"Restoring DNA repair capacity of cells from three distinct diseases by XPD gene-recombinant adenovirus.","date":"2005","source":"Cancer gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/15650764","citation_count":17,"is_preprint":false},{"pmid":"20482310","id":"PMC_20482310","title":"The XPD helicase: XPanDing archaeal XPD structures to get a grip on human DNA repair.","date":"2010","source":"Biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20482310","citation_count":16,"is_preprint":false},{"pmid":"15534626","id":"PMC_15534626","title":"Interethnic variability of ERCC2 polymorphisms.","date":"2005","source":"The pharmacogenomics journal","url":"https://pubmed.ncbi.nlm.nih.gov/15534626","citation_count":16,"is_preprint":false},{"pmid":"26130668","id":"PMC_26130668","title":"Nucleotide Excision Repair Gene ERCC2 and ERCC5 Variants Increase Risk of Uterine Cervical Cancer.","date":"2015","source":"Cancer research and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/26130668","citation_count":16,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51806,"output_tokens":6566,"usd":0.126954,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":15564,"output_tokens":4819,"usd":0.099147,"stage2_stop_reason":"end_turn"},"total_usd":0.226101,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1994,\n      \"finding\": \"ERCC2/XPD protein co-purifies with the RNA polymerase II transcription factor BTF2/TFIIH; antibodies against ERCC3 (p89) or p62 subunit of BTF2 can immunoprecipitate ERCC2, and conversely an anti-ERCC2 antibody retains BTF2. ERCC2 can be salt-resolved from other BTF2 components, and its re-addition enhances BTF2 transcription activity, indicating ERCC2 is a functional subunit of TFIIH involved in both NER and transcription.\",\n      \"method\": \"Co-purification, immunoprecipitation, glycerol gradient sedimentation, transcription activity reconstitution\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — reciprocal immunoprecipitation plus functional reconstitution of transcription activity; foundational paper replicated extensively\",\n      \"pmids\": [\"8194528\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"XPD (ERCC2) and XPB are components of the p53-mediated apoptosis pathway. Primary fibroblasts from XP-D patients (deficient in XPD) have a deficiency in p53-induced apoptosis that can be rescued by transferring wild-type XPD gene into the mutant cells. XP-D lymphocytes also show decreased apoptotic response to DNA damage by adriamycin. XP-A and XP-C mutant cells do not show this apoptotic deficiency, placing XPD specifically in the p53 apoptotic pathway downstream of p53 but upstream of ICE-family caspases.\",\n      \"method\": \"Microinjection of p53 expression vector into primary fibroblasts, retroviral infection, genetic complementation with wild-type XPD gene, comparison across XP complementation groups\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic rescue by wild-type gene in patient cells, epistasis across multiple XP complementation groups, multiple orthogonal methods\",\n      \"pmids\": [\"8675009\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Drosophila Xpd negatively regulates CAK (Cdk7-cyclin H-MAT1) activity within TFIIH. Excess Xpd titrates CAK activity, resulting in decreased Cdk T-loop phosphorylation, mitotic defects, and lethality; conversely, reduced Xpd increases CAK activity and cell proliferation. Xpd is downregulated at the onset of mitosis, which appears to upregulate mitotic CAK activity and promotes mitotic progression.\",\n      \"method\": \"Drosophila genetics (overexpression and loss-of-function), Cdk T-loop phosphorylation assays, mitosis/lethality phenotype analysis\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — gain- and loss-of-function in intact organism with biochemical readout (CAK phosphorylation), mechanistic pathway placement\",\n      \"pmids\": [\"12853965\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"XPD (and FancJ) contain a conserved iron-sulfur (Fe-S) cluster domain near the N-terminus coordinated by three absolutely conserved cysteine residues; this Fe-S cluster is essential for XPD helicase activity. Yeast strains with mutations in the Fe-S domain of Rad3 (yeast XPD ortholog) are defective in UV photoproduct excision repair. Clinically relevant TTD mutations disrupt the Fe-S cluster and abolish helicase activity.\",\n      \"method\": \"Biochemical Fe-S cluster characterization, site-directed mutagenesis of cysteine ligands, in vitro helicase assays, yeast genetic complementation/UV repair assay\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro mutagenesis and helicase assays combined with yeast genetic complementation; replicated in parallel by structural studies\",\n      \"pmids\": [\"16973432\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Crystal structure of XPD catalytic core (from Sulfolobus acidocaldarius) reveals four domains: two Rad51/RecA-like helicase domains (HD1, HD2), a 4FeS domain, and an Arch domain forming a substrate-binding groove. XP mutations along HD1 ATP-binding edge and HD2 DNA-binding channel impair helicase activity essential for NER. XP/CS mutations both impair helicase activity and likely affect HD2 functional movement. TTD mutants map to sites in all four domains causing framework defects that impair TFIIH integrity.\",\n      \"method\": \"X-ray crystallography, in vitro helicase activity assays, mutation analysis\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure combined with biochemical mutant activity assays, disease mutation mapping; independently replicated by second crystal structure paper same year\",\n      \"pmids\": [\"18510924\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"2.25 Å crystal structure of XPD from Sulfolobus tokodaii confirms four-domain organization and reveals that XPD has 5'-to-3' polarity; helicase activity is dependent on the iron-sulfur cluster binding domain. Detailed biochemical analyses provide molecular basis for helicase mechanism and explain phenotypes of XPD mutations in humans.\",\n      \"method\": \"X-ray crystallography (2.25 Å), biochemical helicase assays\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — high-resolution crystal structure with biochemical validation; independent lab, same year as companion paper\",\n      \"pmids\": [\"18510925\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"XPD forms a TFIIH-independent protein complex called MMXD containing MMS19, MIP18 (FAM96B), Ciao1, and ANT2. MMS19, MIP18, and XPD localize to the mitotic spindle during mitosis. siRNA knockdown of MMS19, MIP18, or XPD causes improper chromosome segregation and accumulation of nuclei with abnormal shapes. XP-D and XP-D/CS patient cells also show increased frequency of abnormal mitosis.\",\n      \"method\": \"Protein complex purification/mass spectrometry, co-immunoprecipitation, siRNA knockdown, immunofluorescence localization during mitosis, analysis of patient cells\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — complex purification with MS identification, reciprocal validation, siRNA phenotype, and patient cell confirmation; multiple orthogonal methods\",\n      \"pmids\": [\"20797633\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Drosophila Xpd regulates Cdk7 (CAK) subcellular localization during mitosis: loss of Xpd causes mislocalization of Cdk7/CAK and altered local mitotic kinase activity, leading to defects in spindle dynamics, improper chromosome segregation, multipolar spindles, and aneuploidy. This function is independent of NER and transcription.\",\n      \"method\": \"Drosophila genetics (xpd loss-of-function in early embryos), live imaging, immunofluorescence of Cdk7 localization, kinase activity assays, chromosome segregation analysis\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic loss-of-function with direct localization imaging and kinase activity readout; NER/transcription independence established in transcription-free embryo system\",\n      \"pmids\": [\"20300654\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"XPD generates ATP-stimulated, DNA-mediated redox signaling via its [4Fe-4S] cluster. Using DNA-modified electrodes, XPD shows a DNA-bound redox potential of ~80 mV vs. NHE, similar to base excision repair proteins. The redox signal increases with ATP hydrolysis and is substrate-dependent, reporting on DNA conformational changes associated with enzymatic function.\",\n      \"method\": \"DNA-modified electrochemical electrodes, redox signal measurement, ATP hydrolysis assay\",\n      \"journal\": \"Journal of the American Chemical Society\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro electrochemistry with novel method, single lab, no independent replication reported\",\n      \"pmids\": [\"21939244\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"XPB and XPD helicases within TFIIH asymmetrically unwind dsDNA flanking DNA damage; XPD anchors the CAK kinase complex (cyclinH, MAT1, CDK7) to TFIIH, coordinating NER with transcription and cell cycle through CAK signaling. XPB acts as an ATPase/translocase to open DNA at the damage site, while XPD verifies damage identity.\",\n      \"method\": \"Structural biology review integrating crystal structures, NMR, and EM data with biochemical and cellular information; functional model synthesis\",\n      \"journal\": \"DNA repair\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — mechanistic model integrating multiple structural and biochemical studies from multiple labs, but this paper itself is a review/synthesis rather than primary experiment\",\n      \"pmids\": [\"21571596\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"In TFIIH, XPD helicase activity (requiring DNA binding, ATPase, and 4Fe4S domain integrity) is exclusively devoted to NER and is dispensable for transcription initiation. The p44 subunit activates XPD by stimulating its ATPase activity. Mutations in the 4Fe4S cluster domain abolish NER without affecting transcriptional activity of TFIIH.\",\n      \"method\": \"Comparative biochemical analysis (in vitro and in vivo) of human and Chaetomium thermophilum XPD; ATPase assays, NER complementation assays, transcription assays, mutagenesis of 4Fe4S domain\",\n      \"journal\": \"PLoS biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro and in vivo assays with mutagenesis dissecting NER vs. transcription functions; multiple orthogonal methods in one rigorous study\",\n      \"pmids\": [\"25268380\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Somatic ERCC2 mutations in muscle-invasive urothelial carcinoma impair NER function: expression of representative ERCC2 tumor-derived mutants in an ERCC2-deficient cell line failed to rescue cisplatin sensitivity and UV sensitivity compared with wild-type ERCC2, demonstrating loss of normal ERCC2 function contributes to cisplatin sensitivity.\",\n      \"method\": \"Whole-exome sequencing of patient tumors, functional complementation of ERCC2-deficient cells with mutant vs. wild-type ERCC2, cisplatin and UV cytotoxicity assays\",\n      \"journal\": \"Cancer discovery\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — functional complementation assays with multiple patient-derived mutants vs. wild-type in isogenic cell system, combined with clinical genomics\",\n      \"pmids\": [\"25096233\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"XPD localizes to the inner membrane of mitochondria; oxidative stress enhances XPD recruitment into the mitochondrial compartment. Knockdown of XPD in U2OS cells or XPD-deficient fibroblasts increases mitochondrial ROS, elevates mtDNA common deletion levels, and reduces oxidative damage repair capacity in mtDNA. Immunoprecipitation-mass spectrometry identified TUFM (mitochondrial Tu translation elongation factor) as a physical interaction partner of XPD in mitochondria; TUFM knockdown phenocopies XPD deficiency for mtDNA damage.\",\n      \"method\": \"Subcellular fractionation/Western blot, immunofluorescence localization, siRNA knockdown, mtDNA common deletion assay, oxidative damage repair assay, immunoprecipitation-mass spectrometry\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization by fractionation with functional consequence, IP-MS identification of TUFM, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"25969448\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"DNA loading by XPD proceeds via initial tight ssDNA binding to helicase domain 2, followed by transient opening of the Arch–4FeS domain interface allowing access to a second binding site on helicase domain 1 that directs DNA through the pore. Crystal structure of Sulfolobus acidocaldiarius XPD lacking helicase domain 2 shows otherwise unperturbed architecture, emphasizing the stability of the Arch–4FeS interface.\",\n      \"method\": \"X-ray crystallography, chemical cross-linking, modified DNA substrates, biochemical binding assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure plus cross-linking and biochemical assays in single rigorous study defining loading mechanism\",\n      \"pmids\": [\"26896802\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The Arch domain of XPD interacts with MAT1 (a component of the CDK-activating kinase complex); mutagenesis of the Arch–MAT1 interface impairs both NER (by reducing helicase activity or disrupting XPD–XPG interaction) and RNA polymerase II phosphorylation/RNA synthesis, demonstrating the Arch domain is mechanistically essential for both NER and transcription within TFIIH.\",\n      \"method\": \"Crystal structure of XPD Arch domain with MAT1, mutagenesis of interface residues, NER complementation assay, XPD helicase assay, XPD–XPG interaction assay, RNA synthesis/RNAP II phosphorylation assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure combined with mutagenesis, multiple functional assays (NER, transcription, protein interactions) in one rigorous study\",\n      \"pmids\": [\"32245994\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Arsenic exposure leads to promoter hypomethylation of ERCC2 and ~2-fold overexpression of ERCC2 protein, but this overexpression causes increased association of Cdk7 with ERCC2 (demonstrated by immunoprecipitation/Western blot), resulting in decreased CAK activity (reduced Ser392-p53 phosphorylation) and impaired DNA repair despite higher ERCC2 levels.\",\n      \"method\": \"Bisulfite-methylation-specific PCR, immunoprecipitation/Western blot, in vitro CAK activity assay (p53 Ser392 phosphorylation), micronuclei assay\",\n      \"journal\": \"Metallomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — immunoprecipitation and in vitro kinase assay, single lab, human cohort + cell line validation\",\n      \"pmids\": [\"24473091\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Different mutations in the XPD/ERCC2 gene produce distinct clinical phenotypes (XP vs. TTD). Allele-specific yeast complementation assays showed that the same nucleotide change at certain positions can cause either XP or TTD depending on the second allele; null mutations at shared positions indicate that the phenotype is determined by the other (non-null) allele. Most TTD mutations cluster in a region (amino acids 713–730 and helicase motif areas) distinct from typical XP mutations.\",\n      \"method\": \"ERCC2 cDNA sequencing from patient cell lines, yeast complementation assay of individual alleles\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — allele-specific complementation in yeast for multiple patient alleles; mechanistic placement of mutation sites to phenotype\",\n      \"pmids\": [\"9238033\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"XPB (ERCC3) and XPD (ERCC2) play a principal role in the degradation of retroviral cDNA in the nucleus. XPB and XPD mutant cells exhibit increased transduction efficiency by HIV- and MLV-based retroviral vectors, increased total cDNA, integrated provirus, and 2-LTR circles. XPA mutant cells do not show this effect, placing the function specifically in XPB/XPD but not the broader NER pathway.\",\n      \"method\": \"Retroviral transduction assays in XPB/XPD/XPA mutant cell lines, quantitative PCR for cDNA/integration/2-LTR circles, reverse transcription inhibitor experiments\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function cell lines with defined phenotype, epistasis (XPA negative), multiple viral systems; single lab\",\n      \"pmids\": [\"16537383\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MD simulations of human XPD bound to ssDNA containing a (6-4)PP UV photoproduct identify key residues involved in damage verification: FeS domain residues R112, R196, H135, K128; Arch domain residues E377 and R380; and ATPase lobe 1 residues 215–221. Arch and ATPase lobe 1 domain movements relative to the FeS domain modulate DNA–residue interactions to discriminate damaged from undamaged nucleotides, leading to XPD stalling at the lesion.\",\n      \"method\": \"All-atom molecular dynamics simulations of human XPD with undamaged and 6-4PP-damaged ssDNA\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — computational simulation only, no experimental validation of identified residues in this paper\",\n      \"pmids\": [\"35713557\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Insulin regulates XPD expression via the RAS-signaling and p70 S6 kinase pathways in CHO cells transfected with the human insulin receptor. The intracellular XPD protein level is under exclusive control of the RAS-dependent cascade in response to insulin. Short-term high glucose potentiates insulin-dependent XPD regulation and protects against glucose-induced DNA damage, while chronic high glucose impairs insulin's ability to regulate XPD, leading to accumulation of DNA damage.\",\n      \"method\": \"Signaling pathway inhibitor experiments (RAS, p70 S6 kinase), Western blot, qRT-PCR, comet assay in CHO cells with human insulin receptor\",\n      \"journal\": \"Molecular and cellular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — pathway dissection with pharmacological inhibitors and functional DNA damage readout, single lab\",\n      \"pmids\": [\"12706296\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"XPD mutations are associated with abnormal TFIIH-dependent transactivation of nuclear receptor for vitamin D (VDR). Cells from TTD, XP, and XP/TTD patients with specific XPD mutation pairs showed reduced (5 patients) or elevated (1 patient) vitamin D stimulation ratios of CYP24 and osteopontin, demonstrating that XPD serves as a structural bridge between TFIIH core and the CAK complex to regulate nuclear receptor-mediated transcription.\",\n      \"method\": \"Nuclear receptor transactivation reporter assays (CYP24, osteopontin expression after vitamin D stimulation) in primary patient fibroblasts from XPD compound heterozygotes\",\n      \"journal\": \"European journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional transactivation assays in multiple patient-derived cell lines with defined mutations, multiple nuclear receptor targets\",\n      \"pmids\": [\"23232694\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"XPD suppresses HCC cell proliferation and migration via regulation of miR-29a-3p expression. miR-29a-3p directly targets Mdm2 and PDGF-B (confirmed by dual-luciferase reporter assay), and XPD suppresses proliferation and migration of HCC cells through this XPD→miR-29a-3p→Mdm2/PDGF-B axis.\",\n      \"method\": \"Western blot, qRT-PCR, MTT proliferation assay, transwell migration assay, dual-luciferase reporter assay for miR-29a-3p targets\",\n      \"journal\": \"Cell & bioscience\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, overexpression/knockdown with cellular phenotype and reporter assay, mechanistic pathway proposed but not deeply validated\",\n      \"pmids\": [\"30627419\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"XPD-mutated cell lines (XP, XP-D/CS, TTD) are sensitive to oxidative stress (photoactivated methylene blue and KBrO3). XP-D/CS and TTD cells have severely impaired repair capacity for oxidized lesions in plasmid DNA (host cell reactivation assay) and accumulate more DNA strand breaks after oxidative treatment than wild-type, with persistent γ-H2AX and S/G2 arrest, demonstrating XPD participates in repair of oxidatively-induced DNA lesions.\",\n      \"method\": \"Host cell reactivation assay, alkaline comet assay, γ-H2AX immunofluorescence, cell cycle analysis, survival assays in patient-derived XPD-mutated cell lines\",\n      \"journal\": \"Mutagenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal assays in patient-derived cell lines with defined XPD mutations; single lab\",\n      \"pmids\": [\"31348825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"NOP2-mediated m5C methylation of XPD mRNA elevates XPD mRNA stability and expression. NOP2 overexpression in HCC cells enhances XPD expression by increasing m5C methylation of XPD mRNA, which inhibits proliferation, migration, and invasion of HCC cells in vitro.\",\n      \"method\": \"In vitro cell overexpression, m5C methylation assay, Western blot, proliferation/migration/invasion assays\",\n      \"journal\": \"Neoplasma\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, single method for m5C modification, limited mechanistic detail in abstract\",\n      \"pmids\": [\"37498063\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ERCC2/XPD is an ATP-dependent 5'-to-3' DNA helicase with an essential iron-sulfur (4Fe-4S) cluster domain that functions as a core subunit of the TFIIH complex: within TFIIH it verifies and unwinds DNA at lesion sites during nucleotide excision repair (its helicase activity being exclusively devoted to NER), acts as a structural scaffold for transcription initiation without requiring its enzymatic activity, anchors the CDK-activating kinase (CAK: CDK7-cyclin H-MAT1) to TFIIH to coordinate NER with transcription and cell-cycle progression, and—through its Arch domain interaction with MAT1—regulates nuclear receptor-mediated transactivation; independently of TFIIH, XPD participates in chromosome segregation as part of the MMXD complex (with MMS19, MIP18, Ciao1, ANT2) at the mitotic spindle, localizes to mitochondria to protect mtDNA from oxidative damage, and contributes to p53-dependent apoptosis and retroviral cDNA degradation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ERCC2/XPD is an ATP-dependent 5'-to-3' DNA helicase that functions as a core subunit of the RNA polymerase II transcription factor TFIIH, coordinating nucleotide excision repair (NER) with transcription [#0, #10]. Its catalytic core comprises two RecA-like helicase domains (HD1, HD2), an Arch domain, and an N-terminal [4Fe-4S] cluster domain coordinated by conserved cysteines that is strictly required for helicase activity [#3, #4, #5]. Within TFIIH, XPD's helicase activity—dependent on DNA binding, ATPase function, and 4Fe-4S domain integrity, and stimulated by the p44 subunit—is devoted exclusively to NER and is dispensable for transcription initiation, where XPD instead acts as a structural scaffold [#10]. During lesion processing XPD verifies damage identity while loading DNA through a pore via a tightly held Arch–4FeS interface and a transient opening that exposes a second DNA-binding site [#13], and damage discrimination involves coordinated Arch, FeS, and ATPase-domain movements that stall XPD at lesions [#18]. Through its Arch domain XPD anchors the CDK-activating kinase (CAK; CDK7–cyclin H–MAT1) to TFIIH, contacting MAT1 to link NER and transcription with cell-cycle and nuclear-receptor-mediated transactivation [#14, #20], and regulation of CAK localization and activity by XPD controls mitotic progression [#2, #7]. Independently of TFIIH, XPD assembles into the MMXD complex (MMS19, MIP18/FAM96B, Ciao1, ANT2) at the mitotic spindle to ensure proper chromosome segregation [#6], localizes to mitochondria where it interacts with TUFM to protect mtDNA from oxidative damage [#12], and acts in the p53-dependent apoptotic response to DNA damage [#1]. Distinct XPD mutations produce the clinically distinct phenotypes xeroderma pigmentosum and trichothiodystrophy depending on the affected domain and the second allele [#16], and loss-of-function somatic ERCC2 mutations in urothelial carcinoma impair NER and confer cisplatin sensitivity [#11].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Established that ERCC2/XPD is a functional subunit of TFIIH, physically linking it to both NER and RNA polymerase II transcription and explaining why a repair gene also affects transcription.\",\n      \"evidence\": \"Co-purification, reciprocal immunoprecipitation, and transcription reconstitution of ERCC2 with BTF2/TFIIH\",\n      \"pmids\": [\"8194528\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve the catalytic mechanism within TFIIH\", \"Did not separate transcription vs. repair contributions\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Placed XPD specifically in the p53-dependent apoptotic pathway downstream of p53 and upstream of caspases, distinguishing it from other XP factors.\",\n      \"evidence\": \"p53 microinjection and genetic complementation with wild-type XPD in patient fibroblasts, with epistasis across XP complementation groups\",\n      \"pmids\": [\"8675009\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism linking XPD to p53 apoptosis not defined\", \"Whether this depends on helicase or TFIIH function unknown\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Showed that distinct XPD mutations cause distinct clinical syndromes (XP vs. TTD) and that phenotype is allele-dependent, framing XPD as a gene where mutation position dictates which TFIIH function is compromised.\",\n      \"evidence\": \"Patient cDNA sequencing and allele-specific yeast complementation\",\n      \"pmids\": [\"9238033\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of XP vs. TTD mutation effects not yet known\", \"Mechanism of allele interaction unexplained\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Revealed that XPD negatively regulates CAK activity and is downregulated at mitotic onset, connecting XPD dosage to cell-cycle progression beyond its repair role.\",\n      \"evidence\": \"Drosophila gain- and loss-of-function genetics with Cdk T-loop phosphorylation readouts; insulin/RAS-pathway regulation of XPD levels shown separately in CHO cells\",\n      \"pmids\": [\"12853965\", \"12706296\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct biochemical mechanism of CAK inhibition by XPD not resolved\", \"Mammalian relevance of mitotic downregulation untested\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Defined the [4Fe-4S] cluster domain as essential for helicase activity and NER, and revealed an unexpected TFIIH-linked role in degrading retroviral cDNA distinct from canonical NER.\",\n      \"evidence\": \"Fe-S cluster characterization, cysteine mutagenesis and helicase assays with yeast UV-repair complementation; retroviral transduction assays in XPB/XPD/XPA mutant cells\",\n      \"pmids\": [\"16973432\", \"16537383\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"How the Fe-S cluster contributes mechanically to unwinding not fully defined\", \"Mechanism of retroviral cDNA degradation by XPB/XPD unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Provided the structural framework: a four-domain catalytic core (HD1, HD2, 4FeS, Arch) with 5'-to-3' polarity, mapping disease mutations to functional regions and explaining XP, XP/CS, and TTD phenotypes.\",\n      \"evidence\": \"Two independent X-ray crystal structures of archaeal XPD with biochemical helicase assays and disease-mutation mapping\",\n      \"pmids\": [\"18510924\", \"18510925\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structures are archaeal, not human TFIIH-bound\", \"Dynamic conformational changes during catalysis not captured\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identified a TFIIH-independent function for XPD in chromosome segregation through the MMXD complex at the mitotic spindle, broadening XPD's role beyond repair and transcription.\",\n      \"evidence\": \"MMXD complex purification/MS, reciprocal Co-IP, siRNA segregation phenotypes, and patient-cell analysis; Drosophila imaging of Cdk7/CAK mislocalization upon Xpd loss\",\n      \"pmids\": [\"20797633\", \"20300654\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct molecular role of XPD within MMXD at the spindle unclear\", \"How XPD partitions between TFIIH and MMXD not defined\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Linked the 4Fe-4S cluster to ATP-stimulated DNA-mediated redox signaling and synthesized a mechanistic model of asymmetric DNA unwinding with XPD as the damage-verification helicase anchoring CAK.\",\n      \"evidence\": \"DNA-modified electrochemistry of XPD redox potential; structural-biochemical review synthesizing the XPB/XPD unwinding model\",\n      \"pmids\": [\"21939244\", \"21571596\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Redox signaling shown in vitro only, no independent replication\", \"Physiological role of redox signaling untested in cells\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Cleanly separated XPD's helicase function (exclusively for NER, p44-stimulated) from its scaffolding role in transcription, and demonstrated that loss-of-function ERCC2 mutations in urothelial cancer drive cisplatin sensitivity.\",\n      \"evidence\": \"Comparative biochemistry/mutagenesis of human and C. thermophilum XPD; functional complementation of tumor-derived ERCC2 mutants in ERCC2-deficient cells; arsenic-induced ERCC2 dysregulation via Cdk7 association\",\n      \"pmids\": [\"25268380\", \"25096233\", \"24473091\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How transcription proceeds without XPD catalytic activity not fully detailed\", \"In vivo predictive value of cancer mutations for therapy response not established here\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrated a mitochondrial role: XPD localizes to the inner mitochondrial membrane, interacts with TUFM, and protects mtDNA from oxidative damage, extending XPD function beyond the nucleus.\",\n      \"evidence\": \"Subcellular fractionation, immunofluorescence, siRNA, mtDNA deletion and oxidative-repair assays, and IP-MS identifying TUFM\",\n      \"pmids\": [\"25969448\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Catalytic mechanism of XPD in mtDNA protection unknown\", \"Functional significance of TUFM interaction not mechanistically resolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Resolved the DNA loading mechanism, showing sequential engagement of HD2 then transient Arch–4FeS opening to thread DNA through the pore onto HD1.\",\n      \"evidence\": \"Crystal structure of HD2-deleted archaeal XPD with cross-linking and biochemical DNA-binding assays\",\n      \"pmids\": [\"26896802\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Loading kinetics in the context of full TFIIH not addressed\", \"Coupling to XPB translocation not resolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Established the Arch domain–MAT1 interaction as mechanistically essential for both NER and transcription, unifying XPD's dual roles through a single structural interface.\",\n      \"evidence\": \"Crystal structure of the XPD Arch–MAT1 complex with interface mutagenesis and NER, helicase, XPD–XPG interaction, and RNAP II phosphorylation assays\",\n      \"pmids\": [\"32245994\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How CAK release/retention is dynamically regulated during repair not defined\", \"Link to nuclear-receptor transactivation only indirectly addressed\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Proposed atomic-level residues and domain motions underlying damage verification and lesion-induced stalling of human XPD.\",\n      \"evidence\": \"All-atom molecular dynamics simulations of human XPD with undamaged and 6-4PP-containing ssDNA\",\n      \"pmids\": [\"35713557\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Computational only — identified residues not experimentally validated in this study\", \"Predicted dynamics not confirmed structurally or biochemically\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how XPD dynamically partitions among its TFIIH, MMXD, mitochondrial, and apoptotic functions, and how upstream signals regulate XPD abundance and localization to coordinate these roles.\",\n      \"evidence\": \"No single study in the corpus integrates XPD's multiple complexes and regulatory inputs\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Mechanism partitioning XPD between TFIIH and MMXD unknown\", \"Regulation of mitochondrial recruitment incompletely defined\", \"Cancer-relevant signaling control of XPD levels not mechanistically unified\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [3, 4, 5, 10]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [4, 5, 13]},\n      {\"term_id\": \"GO:0140097\", \"supporting_discovery_ids\": [3, 5, 10, 13]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [10]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [9, 14]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [2, 14]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 17]},\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [6, 7]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [12]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [0, 10, 11]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 10, 14, 20]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [2, 6, 7]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [1]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [11, 16]}\n    ],\n    \"complexes\": [\"TFIIH\", \"MMXD complex\", \"CAK (CDK7-cyclin H-MAT1)\"],\n    \"partners\": [\"ERCC3\", \"GTF2H1\", \"MAT1\", \"CDK7\", \"MMS19\", \"FAM96B\", \"CIAO1\", \"TUFM\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}